Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Petros Pharmaceuticals, Inc. (PTPI) had Return on Tangible Equity of 12.52% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-9.83M |
|
-- |
|
-- |
|
$1.46M |
|
$-1.46M |
|
$0.26M |
|
$-1.20M |
|
$-1.20M |
|
$-1.20M |
|
$-1.20M |
|
$-2.26M |
|
$-1.20M |
|
$-1.46M |
|
$-1.46M |
|
1.16M |
|
1.16M |
|
$-9.37 |
|
$-9.37 |
|
| Balance Sheet Financials | |
$14.47M |
|
-- |
|
$3.14M |
|
$17.61M |
|
$27.13M |
|
-- |
|
$0.06M |
|
$27.19M |
|
$-9.58M |
|
$-9.58M |
|
$-9.58M |
|
2.05M |
|
| Cash Flow Statement Financials | |
$-1.66M |
|
-- |
|
$8.71M |
|
$3.71M |
|
$10.76M |
|
$7.05M |
|
$0.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
12.52% |
|
|
Return on Tangible Equity |
12.52% |
-6.81% |
|
12.52% |
|
$-4.67 |
|
$-1.43 |
|
$-1.43 |
|